Cite
MLA Citation
Eric Sheldon et al.. “Pharmacokinetics, Pharmacodynamics, and Safety of MEDI4212, an Anti-IgE Monoclonal Antibody, in Subjects with Atopy: A Phase I Study.” Advances in therapy, vol. 33, no. 2, 2016, pp. 225–251. http://access.bl.uk/ark:/81055/vdc_100080437615.0x00008a